US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals International

Watchlist
  • 19.740
  • +0.090+0.46%
Close Feb 14 16:00 ET
  • 21.240
  • +1.500+7.60%
Pre 07:00 ET
1.43BMarket Cap-164.50P/E (TTM)

About Kiniksa Pharmaceuticals International Company

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

Company Profile

SymbolKNSA
Company NameKiniksa Pharmaceuticals International
Listing DateMay 24, 2018
Issue Price18.00
Founded2024
CEOMr. Sanj K. Patel
MarketNASDAQ
Employees297
Fiscal Year Ends12-31
Address23 Old Bond Street,3rd Floor
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW1S 4PZ
Phone44-781-431-9100
Websitehttps://www.kiniksa.com

Company Executives

  • Name
  • Position
  • Salary
  • Sanj K. Patel
  • Chief Executive Officer and Chairman of the Board
  • 5.30M
  • Michael R. Megna
  • Chief Accounting Officer and Group Vice President, Finance
  • --
  • Mark Ragosa
  • Senior Vice President and Chief Financial Officer
  • --
  • Eben Tessari
  • Senior Vice President and Chief Operating Officer
  • 1.75M
  • Ross Moat
  • Senior Vice President and Chief Commercial Officer
  • --
  • John F. Paolini, M.D.,PhD
  • Senior Vice President and Chief Medical Officer
  • 1.79M
  • Cantey Boyd
  • Director
  • --
  • Kimberly J. Popovits
  • Independent Director
  • 362.66K
  • Dr. Richard S. Levy,M.D.
  • Independent Director
  • 459.75K
  • Dr. Felix J. Baker,PhD
  • Lead Independent Director
  • 411.06K
  • G. Bradley Cole
  • Independent Director
  • 365.36K
  • Dr. Barry D. Quart,Pharm.D.
  • Independent Director
  • 372.55K
  • Tracey L. McCain, Esq.
  • Independent Director
  • 365.36K
  • Thomas R. Malley
  • Independent Director
  • 380.36K
  • Dr. Stephen R. Biggar,M.D.,PhD
  • Independent Director
  • 371.96K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025